Literature DB >> 3911879

Relevance of serum protein binding of cefoxitin and cefazolin to their activities against Klebsiella pneumoniae pneumonia in rats.

I A Bakker-Woudenberg, J C van den Berg, T B Vree, A M Baars, M F Michel.   

Abstract

An experimental Klebsiella pneumoniae pneumonia in rats was used to study the effect of protein binding of cefoxitin and cefazolin on their therapeutic activity. Both cephalosporins were similar with respect to their antimicrobial activity against the K. pneumoniae in vitro, but they differed in their degree of protein binding, being 34% for cefoxitin and 89 to 93% for cefazolin in uninfected rats and 24 and 71 to 83%, respectively, in infected rats. Various doses of these agents were administered by continuous infusion, which started 5 h after bacterial inoculation and continued for 65 h. Antimicrobial response was evaluated with respect to the numbers of bacteria recovered from lung and blood at the end of treatment. An inhibitory effect of protein binding on the in vivo antimicrobial activity was demonstrated. Cefoxitin was therapeutically effective at a constant plasma level that reached the MIC. To obtain a similar effect with cefazolin the plasma level of that drug had to be increased to a concentration more than three times the MIC.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3911879      PMCID: PMC176351          DOI: 10.1128/AAC.28.5.654

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

Review 1.  Pharmacokinetics and clinical use of cephalosporin antibiotics.

Authors:  C H Nightingale; D S Greene; R Quintiliani
Journal:  J Pharm Sci       Date:  1975-12       Impact factor: 3.534

2.  Comparative studies of the activity of ciclacillin and dicloxacillin.

Authors:  H Mückter; H Sous; G Poszich; P Arend
Journal:  Chemotherapy       Date:  1976       Impact factor: 2.544

3.  Protein binding and concentrations of cephaloridine and cefazolin in serum and interstitial fluid of dogs.

Authors:  N G Waterman; M J Raff; L Scharfenberger; P A Barnwell
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

4.  Cloxacillin and nafcillin: serum binding and its relationship to antibacterial effect in mice.

Authors:  H Mattie; W R Goslings; E L Noach
Journal:  J Infect Dis       Date:  1973-08       Impact factor: 5.226

5.  Pharmacokinetics of cefazolin compared with four other cephalosporins.

Authors:  W M Kirby; C Regamey
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

6.  Penetration of antibiotics into fibrin loci in vivo. II. Comparison of nine antibiotics: effect of dose and degree of protein binding.

Authors:  M Barza; T Samuelson; L Weinstein
Journal:  J Infect Dis       Date:  1974-01       Impact factor: 5.226

7.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

8.  Effect of protein concentration and binding on antibiotic assays.

Authors:  L R Peterson; E A Schierl; W H Hall
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

9.  Pharmacokinetics and comparative pharmacology of cefoxitin and cephalosporins.

Authors:  J J Schrogie; J D Rogers; K C Yeh; R O Davies; G I Holmes; H Skeggs; C M Martin
Journal:  Rev Infect Dis       Date:  1979 Jan-Feb

10.  Interaction of purulent material with antibiotics used to treat Pseudomonas infections.

Authors:  R E Bryant; D Hammond
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

View more
  15 in total

1.  Antimicrobial activity of ceftriaxone compared with cefotaxime in the presence of serum albumin.

Authors:  S K Nath; G A Foster; L A Mandell; C Rotstein
Journal:  Can J Infect Dis       Date:  1995-01

2.  Cefoxitin Plasma and Subcutaneous Adipose Tissue Concentration in Patients Undergoing Sleeve Gastrectomy.

Authors:  Luigi Brunetti; Leonid Kagan; Glenn Forrester; Lauren M Aleksunes; Hongxia Lin; Steven Buyske; Ronald G Nahass
Journal:  Clin Ther       Date:  2015-12-11       Impact factor: 3.393

3.  Effect of treatment duration on pharmacokinetic/pharmacodynamic indices correlating with therapeutic efficacy of ceftazidime in experimental Klebsiella pneumoniae lung infection.

Authors:  Irma A J M Bakker-Woudenberg; Marian T ten Kate; Wil H F Goessens; Johan W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 4.  Serum bactericidal test.

Authors:  C W Stratton
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

5.  Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum.

Authors:  R N Jones; A L Barry
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

6.  Effect of protein binding on serum bactericidal activities of ceftazidime and cefoperazone in healthy volunteers.

Authors:  Y W Lam; M H Duroux; J G Gambertoglio; S L Barriere; B J Guglielmo
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

7.  Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats.

Authors:  R Roosendaal; I A Bakker-Woudenberg; M van den Berghe-van Raffe; J C Vink-van den Berg; M F Michel
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

8.  Influence of dose frequency on the therapeutic efficacies of ciprofloxacin and ceftazidime in experimental Klebsiella pneumoniae pneumonia and septicemia in relation to their bactericidal activities in vitro.

Authors:  R Roosendaal; I A Bakker-Woudenberg; M van den Berghe-van Raffe; J C Vink-van den Berg; M F Michel
Journal:  Pharm Weekbl Sci       Date:  1987-12-11

9.  Pharmacodynamics of levofloxacin and ciprofloxacin in a murine pneumonia model: peak concentration/MIC versus area under the curve/MIC ratios.

Authors:  F Scaglione; J W Mouton; R Mattina; F Fraschini
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

10.  High Levels of Cyclic Di-GMP in Klebsiella pneumoniae Attenuate Virulence in the Lung.

Authors:  David A Rosen; Joy Twentyman; David A Hunstad
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.